SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) was down 1.2% on Friday . The company traded as low as $24.38 and last traded at $24.38. Approximately 200 shares were traded during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The firm has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81. The firm’s fifty day moving average is $24.38 and its 200-day moving average is $24.38.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Featured Articles
- Five stocks we like better than SWEDISH ORPHAN/S
- Do ETFs Pay Dividends? What You Need to Know
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Why Are Stock Sectors Important to Successful Investing?
- MarketBeat Week in Review – 03/24 – 03/28
- Health Care Stocks Explained: Why You Might Want to Invest
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
